tumor cell-based vaccine therapy

BIOLOGICAL2 trials

Sponsors

University of Nebraska

Conditions

Lymphoma

Phase 2

Vaccine Therapy Plus Sargramostim Following Chemotherapy in Treating Stage III or Stage IV Non-Hodgkin's Lymphoma

CompletedNCT00004198

University of NebraskaLymphoma

Start: 1999-06-25End: 2003-11-20Updated: 2023-12-27

Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

CompletedNCT00004197

University of NebraskaLymphoma

Start: 1999-06-25End: 2003-11-20Updated: 2023-09-07